Literature DB >> 4028621

Prostaglandins and nicotinate-provoked increase in cutaneous blood flow.

J K Wilkin, G Fortner, L A Reinhardt, O V Flowers, S J Kilpatrick, W C Streeter.   

Abstract

The mechanism of topically applied methyl nicotinate-induced local cutaneous erythema was studied in normal human subjects. Aqueous methyl nicotinate (0, 0.1, 1.0, 10.0, and 100 mmol/L) was applied to the volar forearms in quadruplicate after oral pretreatments with 25 mg doxepin hydrochloride, 600 mg ibuprofen, 50 mg indomethacin, 975 mg aspirin, and lactose placebo. The cutaneous vascular response was monitored by laser Doppler velocimetry. Although doxepin did not affect the cutaneous vascular response to methyl nicotinate, indomethacin, ibuprofen, and aspirin significantly suppressed the response. Because indomethacin, ibuprofen, and aspirin have different chemical structures, the common property of inhibition of the response to methyl nicotinate may be assigned to their common pharmacologic action, i.e., inhibition of prostaglandin bioformation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4028621     DOI: 10.1038/clpt.1985.170

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  10 in total

1.  Microdialysis technique as a method to study the percutaneous penetration of methyl nicotinate through excised human skin, reconstructed epidermis, and human skin in vivo.

Authors:  E Boelsma; C Anderson; A M Karlsson; M Ponec
Journal:  Pharm Res       Date:  2000-02       Impact factor: 4.200

2.  Cutaneous responses to topical methyl nicotinate in black, oriental, and caucasian subjects.

Authors:  C J Gean; E Tur; H I Maibach; R H Guy
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

Review 3.  Tantalus revisited--the search for the ideal anti-thrombotic dose of aspirin.

Authors:  D Deykin; J A Jakubowski; M J Stampfer; D Faigel
Journal:  Trans Am Clin Climatol Assoc       Date:  1987

4.  Effect of a topical vasodilator on tumor hypoxia and tumor oxygen guided radiotherapy using EPR oximetry.

Authors:  Huagang Hou; Zrinka Abramovic; Jean P Lariviere; Marjeta Sentjurc; Harold Swartz; Nadeem Khan
Journal:  Radiat Res       Date:  2010-05       Impact factor: 2.841

5.  Percutaneous penetration of methyl nicotinate from ointments using the laser Doppler technique: bioequivalence and enhancer effects.

Authors:  Yvonne Remane; Claudia S Leopold; Howard I Maibach
Journal:  J Pharmacokinet Pharmacodyn       Date:  2006-09-28       Impact factor: 2.745

6.  Skin oxygenation after topical application of liposome-entrapped benzyl nicotinate as measured by EPR oximetry in vivo: influence of composition and size.

Authors:  Julijana Kristl; Zrinka Abramović; Marjeta Sentjurc
Journal:  AAPS PharmSci       Date:  2003

7.  Antagonism of the prostaglandin D2 receptor 1 suppresses nicotinic acid-induced vasodilation in mice and humans.

Authors:  Kang Cheng; Tsuei-Ju Wu; Kenneth K Wu; Claudio Sturino; Kathleen Metters; Keith Gottesdiener; Samuel D Wright; Zhaoyin Wang; Gary O'Neill; Eseng Lai; M Gerard Waters
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-14       Impact factor: 11.205

8.  Degradation kinetics of benzyl nicotinate in aqueous solution.

Authors:  C J Mbah
Journal:  Indian J Pharm Sci       Date:  2010-01       Impact factor: 0.975

9.  In vivo determination of the diclofenac skin reservoir: comparison between passive, occlusive, and iontophoretic application.

Authors:  Ron Clijsen; Jean Pierre Baeyens; André Odilon Barel; Peter Clarys
Journal:  Drug Des Devel Ther       Date:  2015-02-13       Impact factor: 4.162

10.  Prevalence and Specificity of the Abnormal Niacin Response: A Potential Endophenotype Marker in Schizophrenia.

Authors:  Jeffrey K Yao; George G Dougherty; Clara H Gautier; Gretchen L Haas; Ruth Condray; John W Kasckow; Benjamin L Kisslinger; John A Gurklis; Erik Messamore
Journal:  Schizophr Bull       Date:  2015-09-14       Impact factor: 9.306

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.